Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: J Pediatr Gastroenterol Nutr. 2012 Apr;54(4):486–490. doi: 10.1097/MPG.0b013e3182382ee3

Figure 2. Quality of life pre-treatment and at 2 weeks.

Figure 2

IMPACT III scores converted as a percent maximum for subjects overall and broken down into those symptomatic and asymptomatic. To obtain raw IMPACT III score, multiply percent maximum by 1.75. Comparison between groups, symptomatic vs. asymptomatic: * p<0.05.